Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 7Sarcoma 6Lymphoma 6Testicular Neoplasms 5Testicular Germ Cell Tumor 5Ovarian Neoplasms 5Osteosarcoma 5Lymphoma, Follicular 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Burkitt Lymphoma 4Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Immunoblastic Lymphadenopathy 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Teratoma 2Solitary Fibrous Tumors 2Small Cell Lung Carcinoma 2Sarcoma, Clear Cell 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangiosarcoma 2Hemangioendothelioma, Epithelioid 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Doxorubicin 3temsirolimus 1resiquimod 1poly ICLC 1nilotinib 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1envafolimab 1enasidenib 1TQ-B3525 1Sunitinib 1Nivolumab 1Methotrexate 1Metformin 1Ifosfamide 1HhAntag691 1Epirubicin 1Dacarbazine 1Cisplatin 1Chloroquine 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Chondrosarcoma × Ifosfamide × Clear all
NCT03277924 2024-08-13

ImmunoSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Completed
197 enrolled
Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡